AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
"Smart bomb' drugs promising
AstraZeneca's tablet Iressa and ImClone's injectable drug C225 are the first in a new class of drugs that aim to knock out cancer cells without damaging healthy tissue. In trials, Iressa shrank lung tumors by half in 19% of patients while 24% responded to ImClone's drug. Both should hit the market next year and are being toted as $1 bil-a-year drugs.
Melanoma vaccine effective, safe
The vaccine is different from others because it's tailor-made to a patient's tumor, Italian scientists said. In trials, Oncophage stimulated cellular immunity, which is required to destroy cancerous cells.
High ...